Therefore, the identification of a tumor suppressor gene silenced by promoter hypermethylation in a specific cancer type provides a rational basis for constructing such a promoter-driven BLI reporter system for the DNMT inhibitor HTS. The gene discussed is DNMT1; the disease is cancer.